Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sorrento Therapeutics Inc SRNE

Sorrento Therapeutics, Inc. is a clinical and commercial stage biopharmaceutical company. The Company is engaged in developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune diseases and COVID-19. The Company’s segments include Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery modalities to generate the next-generation of cancer therapeutics. The Scilex segment is organized around its non-opioid pain management operations and clinical pipeline. The Company’s immuno-oncology platforms, including its fully human antibodies (G-MAB library), ACEA small molecule library, immuno-cellular therapies (DAR-T), antibody-drug conjugates (ADCs) and oncolytic virus (Seprehvec). The Company is also developing potential antiviral therapies against COVID-19, including FUJOVEE (Abivertinib) and its rapid diagnostic test, including COVIMARK.


GREY:SRNE - Post by User

Post by TMAZZ21on Apr 13, 2024 3:28pm
115 Views
Post# 35987634

SCLX DIVIDENDS

SCLX DIVIDENDS
Any other Canadians on here?
 
Writing up a letter to the CRA - Canada Revenue Agency when sending in my taxes. 
Regarding the distribution and valuation of the SCLX shares.
 
Please reply with the name of the brokers and how they classified the dividends and the value of the share price!
 
I know the Americans got it right, but some of the Canadian brokers thinks we should be paying taxes on something that we haven't received - SCLX shares!
 
I will start,
 
Scotia Itrade 
Classification- Income fully taxable
Value of shares - $10.56 USD
 
I'm in discussions with my brokerage who won't change their stance on the SLXC dividends that we received. 
To me it's like fraudulently reporting of income!
 But Scotia couldn't care less,
All I can say is goodbye Itrade l had enough of this illogical thinking and in action!
<< Previous
Bullboard Posts
Next >>